Cargando…
Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma
This analysis assessed the effect of lenalidomide on progression-free survival (PFS). Patients with relapsed or refractory multiple myeloma (RRMM) who received lenalidomide plus dexamethasone in the MM-009 and MM-010 trials were pooled and those who had not progressed and were still receiving lenali...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194066/ https://www.ncbi.nlm.nih.gov/pubmed/21747400 http://dx.doi.org/10.1038/leu.2011.126 |